Events

Immuno-Oncology School

Date : 29.10.2020
Place: Online

Chairman of the school



kaprin
Andrei Dmitrievich Kaprin - President ADIOR CIS and EA, the General Director of "SMRC radiology" of Ministry of health of Russia, the main non-staff oncologist of Ministry of health of Russia, MD, Professor, academician of the Russian Academy of Sciences.

School moderators

filonenko
Filonenko Elena Vyacheslavovna

The President of the Russian Photodynamic Association, Executive Director of ADYAR CIS and EA, head of the center of laser and photodynamic diagnosis and therapy of tumors of the mnioi. P. A. Herzen - branch fgbu "SMRC radiology" of Ministry of healthcare of Russia, head of the unit for the study of melanoma of the fgbi "SMRC radiology" the Ministry of health, the doctor-oncologist, doctor of medical Sciences, Professor.
ryabov
Palatova Jamila Sugartown

Scientific head of Department of tumors of the musculoskeletal system, M. D. senior scientific worker of the Republican specialized Scientific-practical Medical Centre of Oncology and Radiology of Ministry of health of the Republic of Uzbekistan (Snptower), Head of the Department of Oncology and medical radiology of the Tashkent state dental Institute, Secretary General of the Association of oncologists of Uzbekistan.

School program

10:00 – 10:10
Opening. Welcome speech

Kaprin Andrey Dmitrievich
10:10 – 10:30
A clinical example of the use of a PD-1 inhibitor in non-small cell lung cancer after preliminary treatment

Teplyakova Maria Andreevna (Rostov-on-don)

Discussion. Response to question.
10:30–10:50
See beyond the visible: identify residual disease and assess treatment response - circulating tumor DNA as a predictive biomarker in patients with solid cancers. Part I: Features and features of the personalized COO DNA test Signatera

Vasily Aushev, PhD, Senior Scientist, Emerging Technology and Cancer Biology, Natera Inc. USA

Discussion. Response to question.
10:50 – 11:10
See beyond the visible: identify residual disease and assess treatment response - circulating tumor DNA as a predictive biomarker in patients with solid cancers. Part II: Clinical aspects of the use of the personalized COO DNA test Signatera

Dr. Alexey Aleshin, M.D., M.B.A., Senior Medical Director, Oncology, Natera Inc. USA.

Discussion. Response to question.
11:10-11:30
Clinical case of treatment of disseminated melanoma

fayrushina Aigul nailyevna (Kazan)

Discussion. Response to question.
11:30-11:50
Clinical case of immunotherapy for melanoma

Deshkina Tatyana Igorevna (Moscow)

Discussion. Response to question.
11:50-12:10
Clinical case of imunotherapy for kidney cancer

Kachmazov, Andrey Aleksandrovich (Moscow)

Discussion. Response to question.
12:10-13:10
The immune status in children and adolescents with malignant tumors of the nasopharynx

Nargiza Karimova (Tashkent, Uzbekistan)
Palatova Jamila Sugartown (Tashkent, Uzbekistan)
Gildeeva Margarita Sabirova (Tashkent, Uzbekistan)

Discussion. Response to question.
13:10-13:30
Clothing

Организаторы

Association of Directors of Centers and Institutes of Oncology and Radiology of the CIS and Eurasia
FSBI "National Medical Research Center of Radiology" of the Ministry of Health of Russia

Partners

Technical organizer


apmi
For organizational issues, please contact the staff of the Agency for the Support of Medical Initiatives:
7 (495) 109 1069
E-mail: info@medbymed.ru
www.medbymed.ru